Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Risk of atrial fibrillation 900% higher with cancer

Publish date:: July 11, 2019

Key clinical point: Cancer is associated with a significantly increased risk of atrial fibrillation.

Major finding: Individuals with a cancer diagnosis have a 900% higher relative risk of atrial fibrillation than those without cancer.

Study details: A retrospective, population-wide cohort study in 8.3 million people in Austria.

Disclosures: Dr. Ay reported advisory board positions and speaking engagements for the pharmaceutical sector.

Citation:

REPORTING FROM 2019 ISTH CONGRESS

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Patient & Survivor Care

Hemochromatosis variants may confer 10-fold higher risk of liver cancer,

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest,

Reduced cancer mortality with Medicaid expansion,

Risk factors for severe immune-related AEs identified,

New cancer drugs may have saved more than 1.2 million Americans,

All Specialties